Geno NIPT 4
Screens for Down, Edwards and Patau syndromes, combined with assessment of sex chromosome (X, Y) number abnormalities.
Screens for Down, Edwards and Patau syndromes, combined with assessment of sex chromosome (X, Y) number abnormalities.
NIPT is a screening test, not a diagnostic test. Please seek professional advice about eligibility and the meaning of your result.
Understanding NIPT screening
NIPT analyzes cell-free DNA in maternal blood, including DNA originating from the placenta, to assess the chance of selected fetal chromosome conditions. It uses a maternal blood sample without directly sampling the fetus. Packages differ in scope; choose after counseling, not simply by the number of items.
Package screening scope
Three common trisomies
Sex chromosomes
What do these items mean?
Three common trisomies
Assesses the chance of Down syndrome (an extra chromosome 21), Edwards syndrome (an extra chromosome 18) and Patau syndrome (an extra chromosome 13). These are three chromosome-number conditions commonly included in prenatal screening.
Sex chromosomes
Screens for changes in the number of X and Y chromosomes. Geno NIPT 7 lists Turner, Klinefelter, Triple X and Jacobs syndromes. This scope needs specific counseling and is not a test offered to determine fetal sex.
From blood sample to result counseling
Counseling & maternal blood sample
Confirm gestational age, history and package suitability with your clinician before sampling.
DNA analysis
The laboratory analyzes the sample within the chosen panel. Result turnaround: 2–4 days.
Results & follow-up counseling
Your clinician explains the risk, the result’s limitations and any follow-up needed.
Results & important limitations
Low risk
Makes the screened conditions less likely but does not exclude them. Continue recommended prenatal care and ultrasound; NIPT does not assess every genetic condition or birth defect.
High risk
Does not diagnose an affected fetus. Seek genetic counseling and discuss diagnostic testing such as chorionic villus sampling or amniocentesis before important medical decisions.
No result / nonreportable result
Does not mean low risk. Your clinician will assess whether repeat sampling, ultrasound or diagnostic testing is appropriate.
Included tests
| Test name | Code | TAT |
|---|---|---|
| Geno NIPT 4 non-invasive prenatal screening | — | 2–4 days |